{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:45:12Z","timestamp":1771267512488,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00430-016-0482-x","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T11:07:32Z","timestamp":1475579252000},"page":"73-75","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of teriflunomide on QuantiFERON-TB Gold results"],"prefix":"10.1007","volume":"206","author":[{"given":"Alessandra","family":"Bua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Molicotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"key":"482_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","volume":"31","author":"BD Trapp","year":"2008","unstructured":"Trapp BD, Nave KA (2008) Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31:247\u2013269","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"482_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.mayocp.2013.11.002","volume":"89","author":"DM Wingerchuk","year":"2014","unstructured":"Wingerchuk DM, Carter JL (2014) Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin Proc 89(2):225\u2013240","journal-title":"Mayo Clin Proc"},{"key":"482_CR3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa1014656","volume":"365","author":"P O\u2019Connor","year":"2011","unstructured":"O\u2019Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS, TEMSO Trial Group (2011) Randomized trial of oral teriflunomide for relapsing multiple sclerosis. N Engl J Med 365:1293\u20131303","journal-title":"N Engl J Med"},{"key":"482_CR4","doi-asserted-by":"crossref","first-page":"21682","DOI":"10.1074\/jbc.273.34.21682","volume":"273","author":"K R\u00fcckemann","year":"1998","unstructured":"R\u00fcckemann K, Fairbanks LD, Carrey EA, Hawrylowicz CM, Richards DF, Kirschbaum B, Simmonds HA (1998) Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 273:21682\u201321691","journal-title":"J Biol Chem"},{"key":"482_CR5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1081\/NCN-200027547","volume":"23","author":"M L\u00f6ffler","year":"2004","unstructured":"L\u00f6ffler M, Klein A, Hayek-Ouassini M, Knecht W, Konrad L (2004) Dihydroorotate dehydrogenase mRNA and protein expression analysis in normal and drug-resistant cells. Nucleosides Nucleotides Nucleic Acids 23:1281\u20131285","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"9","key":"482_CR6","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/art.21255","volume":"52","author":"M Zeyda","year":"2005","unstructured":"Zeyda M, Poglitsch M, Geyeregger R, Smolen JS, Zlabinger GJ, H\u00f6rl WH, Waldh\u00e4usl W, Stulnig TM, S\u00e4emann MD (2005) Distruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: involvement of impaired integrin activation and immunologic synapse formation. Arthritis Rheum 52(9):2730\u20132739","journal-title":"Arthritis Rheum"},{"key":"482_CR7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","volume":"37","author":"R Diel","year":"2011","unstructured":"Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D (2011) Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and metaanalysis. Eur Respir J 37:88\u201399","journal-title":"Eur Respir J"},{"issue":"2","key":"482_CR8","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1212\/NXI.0000000000000070","volume":"2","author":"A Bar-Or","year":"2015","unstructured":"Bar-Or A, Wiendl H, Miller B, Benamor M, Truffinet P, Menguy-Vacheron MC (2015) Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigen. Neurol Neuroimmunol Neuroinflamm 2(2):e70","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"482_CR9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2013.10.003","volume":"265","author":"L Li","year":"2013","unstructured":"Li L, Liu J, Deloherya T, Zhang D, Arendt C, Jones C (2013) The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro. J Neuroimmunol 265:82\u201390","journal-title":"J Neuroimmunol"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0482-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-016-0482-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0482-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:18:59Z","timestamp":1498335539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-016-0482-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1007\/s00430-016-0482-x","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]}}}